文献速递消化道肿瘤与早癌消化内镜

颗粒混合型侧向发育型肿瘤隐匿性黏膜下癌风险

Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-07-17

该研究纳入意大利7个中心2016至2019年693例无侵袭征象的结直肠颗粒混合型侧向发育型肿瘤患者,74.2%接受内镜下切除术、25.2%接受内镜黏膜下剥离术。病理分析显示66例(9.5%)存在隐匿性黏膜下浸润癌,多因素分析显示病变增大(每增1mm OR 1.02)和直肠位置(OR 3.08)与风险独立相关。结论认为约10%的GM-LST存在隐匿性SMIC,≥4cm及直肠位置为高风险,应行整块切除。

要点

  • 693例无侵袭征象的结直肠GM-LST中,66例(9.5%)病理证实为隐匿性黏膜下浸润癌。
  • 病变每增大1mm,隐匿性SMIC风险增加(OR 1.02,95%CI 1.01-1.03,P=.003)。
  • 直肠位置与隐匿性SMIC风险独立相关(OR 3.08,95%CI 1.62-5.83,P=.004)。

核心结论

  • 在693例患者的数据分析中,GM-LST患者隐匿性SMIC风险约为10%。
  • ≥4cm的GM-LST及直肠位置属高风险,应行整块切除。

研究设计与样本

  • 多中心研究,收集意大利7个中心2016至2019年693例无侵袭征象的结直肠GM-LST患者数据。
  • 患者中男性50.6%,中位年龄69岁;74.2%接受内镜下切除术,25.2%接受内镜黏膜下剥离术。
  • 采用单因素和多因素分析识别与SMIC风险相关的 demographic 和内镜因素,并建立多因素模型计算需治疗人数(NNT)。

主要发现

  • 病理分析显示66例(9.5%)存在隐匿性SMIC。
  • 多因素分析中,病变增大与隐匿性SMIC风险独立相关(每增1mm OR 1.02,95%CI 1.01-1.03,P=.003)。
  • 直肠位置与隐匿性SMIC风险独立相关(OR 3.08,95%CI 1.62-5.83,P=.004)。
  • 基于病变大小( cutoff 40mm)和直肠位置的逻辑回归模型识别隐匿性SMIC的敏感性47.0%、特异性82.6%、曲线下面积0.69。
  • 识别1例非直肠<4cm的SMIC的NNT为20;识别1例直肠≥4cm的SMIC的NNT为5。

关键数值与推荐

  • 病变大小 cutoff 值为40mm,联合直肠位置构建的逻辑回归模型敏感性47.0%、特异性82.6%、AUC 0.69。
  • 非直肠、病变<4cm者识别1例SMIC的NNT为20;直肠、病变≥4cm者识别1例SMIC的NNT为5。

临床怎么用

  • 作者认为≥4cm的GM-LST及直肠位置为高风险,应行整块切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Granular mixed laterally spreading tumors (GM-LSTs) have an intermediate level of risk for submucosal invasive cancer (SMICs) without clear signs of invasion (covert); the optimal resection method is uncertain. We aimed to determine the risk of covert SMIC in GM-LSTs based on clinical and endoscopic factors. METHODS: We collected data from 693 patients (50.6% male; median age, 69 years) with colorectal GM-LSTs, without signs of invasion, who underwent endoscopic resection (74.2%) or endoscopic submucosal dissection (25.2%) at 7 centers in Italy from 2016 through 2019. We performed multivariate and univariate analyses to identify demographic and endoscopic factors associated with risk of SMIC. We developed a multivariate model to calculate the number needed to treat (NNT) to detect 1 SMIC. RESULTS: Based on pathology analysis, 66 patients (9.5%) had covert SMIC. In multivariate analyses, increased risk of covert SMIC were independently associated with increasing lesion size (odds ratio per mm increase, 1.02, 95% CI, 1.01-1.03; P = .003) and rectal location (odds ratio, 3.08; 95% CI, 1.62-5.83; P = .004). A logistic regression model based on lesion size (with a cutoff of 40 mm) and rectal location identified patients with covert SMIC with 47.0% sensitivity, 82.6% specificity, and an area under the curve of 0.69. The NNT to identify 1 patient with a nonrectal SMIC smaller than 4 cm was 20; the NNT to identify 1 patient with a rectal SMIC of 4 cm or more was 5. CONCLUSIONS: In an analysis of data from 693 patients, we found the risk of covert SMIC in patients with GM-LSTs to be approximately 10%. GM-LSTs of 4 cm or more and a rectal location are high risk and should be treated by en-bloc resection. ClinicalTrials.gov, Number: NCT03836131.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. D'Amico F, Amato A, Iannone A, et al. Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors. Clin Gastroenterol Hepatol. 2020. PMID: 32687977. doi:10.1016/j.cgh.2020.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。